The role of xanthine oxidase in hemodialysis-induced oxidative injury: Relationship with nutritional status

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Miric, Dijana ^a   Kisic, Bojana ^a   Stolic, Radojica ^a   Miric, Bratislav ^b   Mitic, Radoslav ^a   Janicijevic Hudomal, Snezana ^a  

^a Medical Faculty Pristina   (Serbia)

^b STATE UNIVERSITY OF NOVI PAZAR   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION; FREE THIOL GROUP; HEALTHY CONTROLS; LIPID HYDROPEROXIDES; MULTIPLE REGRESSION ANALYSIS; OXIDATIVE INJURY; SUPEROXIDE DISMUTASES; XANTHINE OXIDASE;

BODY FLUIDS; DIALYSIS; HEMODIALYZERS; NUTRITION; OXYGEN; PROTEINS; REGRESSION ANALYSIS;

PATIENT TREATMENT;

ADVANCED OXIDATION PROTEIN PRODUCT; LIPID HYDROPEROXIDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; THIOL GROUP; XANTHINE OXIDASE; ANTIOXIDANT; BIOLOGICAL MARKER; PEROXIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; RISK ASSESSMENT; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PEROXIDASE; REGRESSION ANALYSIS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 84879326745     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/245253     Document Type: Article

References (32)

1. Kalantar-Zadeh K., Balakrishnan V. S., The kidney disease wasting: inflammation, oxidative stress, and diet-gene interaction. Hemodialysis International 2006 10 4 315 325 2-s2.0-33748091826 10.1111/j.1542-4758.2006. 00124.x
2. Capeillère-Blandin C., Gausson V., Nguyen A. T., Descamps-Latscha B., Drüeke T., Witko-Sarsat V., Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrology Dialysis Transplantation 2006 21 6 1555 1563 2-s2.0-33744917848 10.1093/ndt/gfl007
3. Kobayashi I., Ishimura E., Kato Y., Okuno S., Yamamoto T., Yamakawa T., Mori K., Inaba M., Nishizawa Y., Geriatric Nutritional Risk Index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrology Dialysis Transplantation 2010 25 10 3361 3365 2-s2.0-77957241445 10.1093/ndt/gfq211
4. Honda H., Ueda M., Kojima S., Assessment of myeloperoxidase and oxidative a1-antitrypsin in patients on hemodialysis. Clinical Journal of the American Society of Nephrology 2009 4 142 151
5. Honda H., Ueda M., Kojima S., Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients. Clinical Journal of the American Society of Nephrology 2010 5 1021 1028
6. Kuppusamy U. R., Indran M., Ahmad T., Wong S. W., Tan S. Y., Mahmood A. A., Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Clinica Chimica Acta 2005 351 1-2 197 201 2-s2.0-9444233316 10.1016/j.cccn.2004.09.014
7. Obara M., Hirayama A., Gotoh M., Elimination of lipid peroxide during hemodialysis. Nephron Clinical Practice 2007 106 c162 c168
8. Gibbings S., Elkins N. D., Fitzgerald H., Tiao J., Weyman M. E., Shibao G., Fini M. A., Wright R. M., Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor- γ sumoylation, and HIF-1 α Journal of Biological Chemistry 2011 286 2 961 975 2-s2.0-78651409652 10.1074/jbc.M110.150847
9. Pacher P., Nivorozhkin A., Szabó C., Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacological Reviews 2006 58 1 87 114 2-s2.0-33644631485 10.1124/pr.58.1.6
10. Houston M., Estevez A., Chumley P., Aslan M., Marklund S., Parks D. A., Freeman B. A., Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. Journal of Biological Chemistry 1999 274 8 4985 4994 2-s2.0-0033582522 10.1074/jbc.274.8.4985
11. Gwinner W., Scheuer H., Haller H., Brandes R. P., Groene H., Pivotal role of xanthine oxidase in the initiation of tubulointerstitial renal injury in rats with hyperlipidemia. Kidney International 2006 69 3 481 487 2-s2.0-31544478848 10.1038/sj.ki.5000121
12. Kushiyama A., Okubo H., Sakoda H., Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 291 298
13. Choi J. Y., Yoon Y. J., Choi H. J., Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients undergoing hemodialysis. Nephrology Dialysis Transplantation 2011 26 1304 1313
14. Springer J., Tschimer A., Hartman K., Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia. International Journal of Cancer 2012 131 2187 2196
15. Roussos G. G., Xanthine oxidase from bovine small intestine. Methods in Enzymology 1967 12 5 16 2-s2.0-77956989097 10.1016/S0076-6879(67)12005-3
16. Metcalf J. A., Gallin J. I., Nauseef W. M., Root R. K., Myeloperoxidase functional assays. Laboratory Manual of Neutrophil Function 1986 New York, NY, USA Raven Press 150 151
17. Misra H. P., Fridovich I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry 1972 247 10 3170 3175 2-s2.0-0015523099
18. Beutler E., Duron O., Kelly B. M., Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine 1963 61 882 888 2-s2.0-73649194769
19. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Ling K. L. E., Wolff S. P., Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma: relevance to determination of total plasma lipid hydroperoxide concentrations. Biochemical Journal 1996 313 3 781 786 2-s2.0-0030034871
20. Anderstam B., Ann-Christin B., Valli A., Stenvinkel P., Lindholm B., Suliman M. E., Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clinica Chimica Acta 2008 393 2 114 118 2-s2.0-44449094921 10.1016/j.cca.2008.03.029
21. Dobiášová M., Frohlich J., The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FER HDL). Clinical Biochemistry 2001 34 7 583 588 2-s2.0-0035668546 10.1016/S0009-9120(01)00263-6
22. Leypoldt J. K., Cheung A. K., Delmez J. A., Gassman J. J., Levin N. W., Breyer Lewis J. A., Lewis J. L., Rocco M. V., Relationship between volume status and blood pressure during chronic hemodialysis. Kidney International 2002 61 1 266 275 2-s2.0-0036145276 10.1046/j.1523-1755.2002.00099.x
23. Landmesser U., Spiekermann S., Dikalov S., Tatge H., Wilke R., Kohler C., Harrison D. G., Hornig B., Drexler H., Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002 106 24 3073 3078 2-s2.0-0037058827 10.1161/01.CIR.0000041431.57222.AF
24. Radi R., Bush K. M., Cosgrove T. P., Freeman B. A., Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma. Archives of Biochemistry and Biophysics 1991 286 1 117 125 2-s2.0-0025893054
25. Witko-Sarsat V., s Friedlander M., Khoa N. T., Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. Journal of Immunology 1998 161 2524 2532
26. Demirci Ş., Şekerolu M. R., Noyan T., Köçerolu R., Soyoral Y. U., Dülger H., Erkoç R., The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis. Cell Biochemistry and Function 2011 29 3 249 254 2-s2.0-79953717094 10.1002/cbf.1744
27. Ohtsubo T., Rovira I. I., Starost M. F., Liu C., Finkel T., Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2. Circulation Research 2004 95 11 1118 1124 2-s2.0-9344250533 10.1161/01.RES.0000149571.96304. 36
28. Moshage H. J., Janssen J. A. M., Franssen J. H., Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. Journal of Clinical Investigation 1987 79 6 1635 1641 2-s2.0-0023224301
29. McNally J. S., Davis M. E., Giddens D. P., Saha A., Hwang J., Dikalov S., Jo H., Harrison D. G., Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. American Journal of Physiology 2003 285 6 H2290 H2297 2-s2.0-0344185339
30. Biffl W. L., Moore E. E., Splanchnic ischaemia/reperfusion and multiple organ failure. British Journal of Anaesthesia 1996 77 1 59 70 2-s2.0-0030003370
31. Derbre F., Ferrando B., Gomez-Cabrera M. C., Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases. PloS ONE 2012 7 e46668 10.1371/journal.pone.0046668
32. Wang F., Jiang H., Shi K., Ren Y., Zhang P., Cheng S., Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology 2012 17 733 738